Patient-derived fibrin sealant: Clinical, preclinical, and biophysical aspects

Danish Medical Bulletin

Volumn 50, Issue 4, 2003, Pages 293-309

  Kjœrgård, Henrik Kåre ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Copenhagen and Gentofte Hospital ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ANTICOAGULANT AGENT; BIOMATERIAL; BLOOD CLOTTING FACTOR 5; FIBRIN GLUE; FIBRINOGEN; THROMBIN;

ANAPHYLAXIS; ANTICOAGULATION; BIOSAFETY; BLEEDING; BLOOD CLOT RETRACTION; BLOOD VESSEL PROSTHESIS; BREAST SURGERY; CELL ACTIVATION; CLINICAL TRIAL; COMPRESSIVE STRENGTH; COST BENEFIT ANALYSIS; DERIVATIZATION; EAR NOSE THROAT SURGERY; ENZYME DEGRADATION; EVALUATION; EXPERIMENTAL RAT; EYE SURGERY; GASTROINTESTINAL SURGERY; GYNECOLOGIC SURGERY; HEART RUPTURE; HEART SURGERY; HEMOSTASIS; HISTORY; HUMAN; HYPOTHESIS; INFECTION RISK; LABORATORY AUTOMATION; MATERIALS TESTING; MAXILLOFACIAL SURGERY; MEASUREMENT; NEUROSURGERY; NONHUMAN; ORAL SURGERY; ORTHOPEDIC SURGERY; PEROPERATIVE CARE; PLASTIC SURGERY; POSTOPERATIVE CARE; REACTION TIME; REVIEW; STATISTICS; SURGICAL RISK; SURGICAL TECHNIQUE; SWINE; TENSION; THORAX SURGERY; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TREATMENT INDICATION; UROLOGIC SURGERY; VASCULAR SURGERY; VIRUS INFECTION; VIRUS TRANSMISSION; WOUND CLOSURE; WOUND HEALING;

ADHESIVENESS; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPHYSICS; ELASTICITY; FIBRIN TISSUE ADHESIVE; HUMANS; MATERIALS TESTING; PHOTOMICROGRAPHY; RATS; REPRODUCIBILITY OF RESULTS; SWINE; TENSILE STRENGTH;

EID: 0345307288     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (207)

1. Pavie A, Szefner J, Leger P, Gandjbakhch I. Preventing, minimizing, and managing postoperative bleeding. Ann Thorac Surg 1999; 68:705-710.
2. Grey EC. Fibrin as a hemostatic in cerebral surgery. Surg Gynecol Obstet 1915; 21: 452.
3. Harvey SC. The use of fibrin papers and forms in surgery. Boston Med Surg J 1916; 174, 658.
4. Matras H. The use of fibrin sealant in oral and maxillofacial surgery. J Oral Maxillofac Surg 1982; 40:617-622.
5. Immuno. The art of Tisseeling 1995.
6. Centeon. Beriplast Combi-Set 1998.
7. Wilson SM, Pell P Donegan EA. HIV-1 transmission following the use of cryoprecipitated fibrin as gel/adhesive. Transfusion 1991; 31 (suppl):51S.
8. Some blood products recalled by Baxter du to donor's disease. Wall Street Journal 1994.
9. Revocation of fibrinogen licenses. FDA Drug Bulletin 1978; 8:15.
10. Banninger H, Hardegger T, Tobler A, Barth A, Schupbach P, Reinhart W, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993; 85:528-532.
11. Berruyer M, Amiral J, Ffrench P, Belleville J, Bastien O, Clerc J, et al. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993; 105:892-897.
12. Fastenau DR, Hormuth DA, McIntyre JA. Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin. Transplant Proc 1999; 31:141-142.
13. Seifert J, Klause N, Stobbe J, Egbers HJ. Antibodies formed against fibrin glue components and their circulatory relevance. J Invest Surg 1994; 7:167-171.
14. Muntean W, Zenz W, Finding K, Zobel G, Beitzke A. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Paediatr 1994; 83:84-87.
15. Muntean W, Zenz W, Edlinger G, Beitzke A. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost 1997; 77:1223.
16. Christie RJ, Carrington L, Alving B. Postoperative bleeding induced by topical bovine thrombin: report of two cases. Surgery 1997; 121:708-710.
17. Ortel TL, Charles LA, Keller FG, Marcom PK, Oldham HNJ, Kane WH, et al. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 1994; 45:128-135.
18. Chouhan VD, De La Cadena RA, Nagaswami C, Weisel JW, Kajani M, Rao AK. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function. Thromb Haemost 1997; 77:343-349.
19. Rapaport SI, Zivelin A, Minow RA, Hunter CS, Donnelly K. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 1992; 97:84-91.
20. Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990; 76:2011-2016.
21. Nichols WL. Adverse antibody-mediated reactions to topical bovine thrombin and fibrin glue. Conference Fibrin Sealant: Characteristics and clinical uses 1994; 5-10.
22. Nichols WL, Daniels TM, Fisher PK, Owen WG, Pineda AA, Mann KG. Antibodies to bovine thrombin and coagulation factor V associated with surgical use of topical bovine thrombin or fibrin "glue": A frequent finding. Blood 1993; 82 (Suppl 1), 59a (abstract).
23. Ochsner MG, Maniscalco-Theberge ME, Champion HR. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990; 30:884-887.
24. Mosnier LO, von dem B, Meijers JC, Bouma BN. Plasma TAF1 levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost 1998; 80:829-835.
25. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998; 4:909-914.
26. Henrikson KP, Salazar SL, Fenton JW, Pentecost BT. Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 1999; 79:401-406.
27. Paulmier P. The main problem with biological products of animal origin. Biologicals 2000; 28:55.
28. Schwarz TF. Transmission of parvovirus B19 by blood and blood components. Infusionsther Transfusionsmed 1994; 21 (suppl. 1), 27-31.
29. Scheule AM, Beierlein W, Lorenz H, Ziemer G. Repeated anaphylactic reactions to aprotinin in fibrin sealant. Gastrointest Endosc 1998; 48:83-85.
30. Scheule AM, Beierlein W, Wendel HP, Jurmann MJ, Eckstein FS, Ziemer G. Aprotinin in fibrin tissue adhesives induces specific antibody response and increases antibody response of high-dose intravenous application. J Thorac Cardiovasc Surg 1999; 118:348-353.
31. Schlag G, Seifert J. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 1998; 116:1082-1083.
32. Milde LN. An anaphylactic reaction to fibrin glue. Anesth Analg 1989; 69:684-686.
33. Beierlein W, Scheule AM, Ziemer G. Anaphylactic aprotinin reaction. Ann Thorac Surg 2000; 69:1298.
34. Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 2000; 40:302-305.
35. Scheule AM, Beierlein W, Arnold S, Eckstein FS, Albes JM, Ziemer G. The significance of preformed aprotinin-specific antibodies in cardiosurgical patients. Anesth Analg 2000; 90:262-266.
36. Scheule AM, Beierlein W, Wendel HP, Eckstein FS, Heinemann MK, Ziemer G. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 1998; 115:883-889.
37. Beduschi R, Beduschi MC, Wojno KJ, Jhung M, Williams AL, Wolf JS. Antifibrinolytic additives to fibrin glue for laparoscopic wound closure in urinary tract. J Endourol 1999; 13:283-287.
38. Lerner R, Binur NS. Current status of surgical adhesives. J Surg Res 1990; 48:165-181.
39. Dascombe WH, Dumanian G, Hong C, Heil BV, Labadie K, Hessel B, et al. Application of thrombin based fibrin glue and non-thrombin based batroxobin glue on intact human blood vessels: evidence for transmural thrombin activity. Thromb Haemost 1997; 78:947-951.
40. Weis-Fogh US. Fibrinogen prepared from small blood samples for autologous use in a tissue adhesive system. Eur Surg Res 1988; 20:381-389.
41. Dahlstrom KK, Weis-Fogh US, Medgyesi S, Rostgaard J, Sorensen H. The use of autologous fibrin adhesive in skin transplantation. Plast Reconstr Surg 1992; 89:968-972.
42. Kjaergard HK, Weis-Fogh US, Sorensen H, Thiis J, Rygg I. A simple method of preparation of autologous fibrin glue by means of ethanol. Surg Gynecol Obstet 1992; 175:72-73.
43. Kjaergard HK, Weis-Fogh US, Thiis JJ. Preparation of autologous fibrin glue from pericardial blood. Ann Thorac Surg 1993; 55:543-544.
44. Pisciotto PT, Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Sayers MH, et al. Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive. Transfus Sci 1993; 14:291-294.
45. Kjaergard HK, Fairbrother JE, Cederholm-Williams SA, Edwardson PAD, Hollingsbee DA, Holm NE. The Vivostat system for the automated preparation of autologous fibrin sealant. Cardiovascular Engineering 1997; 2, 204-206.
46. Kjaergard HK, Trumbull HR. Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 1998; 66:482-486.
47. Kjaergard HK, Weis-Fogh US. Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time-comparison of strength with commercial fibrin glue. Eur Surg Res 1994; 26:273-276.
48. Kjaergard HK, Weis-Fogh US. Autologous fibrin glue for sealing vascular prostheses of high porosity. Cardiovasc Surg 1994; 2:45-47.
49. Tsuda T, Nakamura T, Yamamoto Y, Teramachi M, Kiyotani T, Lee YH, et al. Prevention of postoperative air leakage from lungs using a purified human collagen membrane-polyglycolic acid sheet. Ann Thorac Surg 1999; 68:339-342.
50. Kjaergard HK, Velada JL, Pulawska T, Ellensen VS, Larsen SS, Hollingsbee DA. Development of a model for measurement of adhesion strength of fibrin sealant to human tissue. Eur Surg Res 1999; 31:491-496.
51. Curtin WA, Wang GJ, Goodman NC, Abbott RD, Spotnitz WD. Reduction of hemorrhage after knee arthroplasty using cryo-based fibrin sealant. J Arthroplasty 1999; 14:481-487.
52. Deprest JA, Papadopulos NA, Decaluw H, Yamamoto H, Lerut TE, Gratacos E. Closure techniques for fetoscopic access sites in the rabbit at mid-gestation. Hum Reprod 1999; 14:1730-1734.
53. Kjaergard HK, Axelsen P. Effectiveness of autologous fibrin sealant in experimental lung surgery. European Surgical Research 1996; 28:162-166.
54. Otani Y, Tabata Y, Ikada Y. Sealing effect of rapidly curable gelatin-poly (L-glutamic acid) hydrogel glue on lung air leak. Ann Thorac Surg 1999; 67:922-926.
55. Buckley RC, Breazeale EE, Edmond JA, Brzezienski MA. A simple preparation of autologous fibrin glue for skin-graft fixation. Plast Reconstr Surg 1999; 103:202-206.
56. Detweiler MB, Kobos JW, Fenton J. Gastrointestinal sutureless anastomosis in pigs using absorbable intraluminal stents, stent placement devices, and fibrin glue - a summary. Langenbecks Arch Surg 1999; 384:445-452.
57. Scardino MS, Swaim SF, Morse BS, Sartin EA, Wright JC, Hoffman CE. Evaluation of fibrin sealants in cutaneous wound closure. J Biomed Mater Res 1999; 48:315-321.
58. Park JJ, Siedentop KH, Chung S, Sanchez B, Bhattacharyya T. Comparison of the bonding power of various autologous fibrin tissue adhesives. Am J Otol 1997; 18:655-659.
59. Siedentop KH, Harris DM, Sanchez B. Autologous fibrin tissue adhesive: factors influencing bonding power. Laryngoscope 1988; 98:731-733.
60. Kjaergard HK, Velada JL, Pedersen JH, Fleron H, Hollingsbee DA. Comparative kinetics of polymerisation of three fibrin sealants and influence on timing of tissue adhesion. Thromb Res 2000; 98:221-228.
61. Burnouf-Radosevich M, Burnouf T, Huart JJ. Biochemical and physical properties of a solvent-detergent-treated fibrin glue. Vox Sang 1990; 58:77-84.
62. Byrne DJ, Hardy J, Wood RA, McIntosh R, Cuschieri A. Effect of fibrin glues on the mechanical properties of healing wounds. Br J Surg 1991; 78:841-843.
63. Flahiff C, Feldman D, Saltz R, Huang S. Mechanical properties of fibrin adhesives for blood vessel anastomosis. J Biomed Mater Res 1992; 26:481-491.
64. Glidden PF, Malaska C, Herring SW. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost 2000; 6:226-233.
65. Hjortrup A, Nordkild P, Christensen T, Sjontoft E, Kjaergaard J. Rectal anastomosis with application of luminal fibrin adhesive in the rectum of dogs. An experimental study. Dis Colon Rectum 1989; 32:422-425.
66. Park MS. Autologous fibrin glue for tympanoplasty. Am J Otol 1994; 15:687-689.
67. Scotte M, Dujardin F, Amelot A, Azema P, Leblanc I, Bouvier P, et al. Experimental measure of the tensile strength of biological sealant-collagen association after hepatectomy in dogs. Eur Surg Res 1996; 28:436-439.
68. Sekine T, Nakamura T, Shimizu Y, Ueda H, Matsumoto K, Takimoto Y, et al. A new type of surgical adhesive made from porcine collagen and polyglutamic acid. J Biomed Mater Res 2001; 54:305-310.
69. Sierra DH, Feldman DS, Saltz R, Huang S. A method to determine shear adhesive strength of fibrin sealants. J Appl Biomater 1992; 3:147-151.
70. Sierra DH, O'Grady K, Toriumi DM, Foresman PA, Rodeheaver GT, Eberhardt A, et al. Modulation of mechanical properties in multiple-component tissue adhesives. J Biomed Mater Res 2000; 52:534-542.
71. Baxter. Tisseel spray set. 1998.
72. Kjaergard HK, Axelsen P, Weis-Fogh US. Repair of experimental atrial rupture with fibrin glue. Injury 1995; 26:147-149.
73. Kjaergard HK, Pedersen JH, Krasnik M, Weis-Fogh US, Fleron H, Griffin HE. Prevention of air leakage by spraying vivostat fibrin sealant after lung resection in pigs. Chest 2000; 117:1124-1127.
74. Kjaergard HK, Weis-Fogh US, Sorensen H, Thiis J, Rygg I. Autologous fibrin glue-preparation and clinical use in thoracic surgery. Eur J Cardiothorac Surg 1992; 6:52-54.
75. Raju TN. The Nobel chronicles. 1926: Johannes Andreas Grib Fibiger (1867-1928). Lancet 1998; 352:1635
76. Kjaergard HK, Fairbrother JE. Controlled clinical studies of fibrin sealant in cardiothoracic surgery - a review. Eur J Cardiothorac Surg 1996; 10:727-733.
77. Schmidt H, Mortensen PE, Folsgaard SL, Jensen EA. Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion. Ann Thorac Surg 1996; 61:1177-1181.
78. Kjaergard HK, Trumbull HR. Bleeding from the sternal marrow can be stopped using vivostat patient-derived fibrin sealant. Ann Thorac Surg 2000; 69:1173-1175.
79. Albes JM, Krettek C, Hausen B, Rohde R, Haverich A, Borst HG. Biophysical properties of the gelatin-resorcin-formaldehyde/glutaraldehyde adhesive. Ann Thorac Surg 1993; 56:910-915.
80. Laitakari K, Luotonen J. Autologous and homologous fibrinogen sealants: adhesive strength. Laryngoscope 1989; 99:974-976.
81. Siedentop KH, Park JJ, Sanchez B. An autologous fibrin tissue adhesive with greater bonding power. Arch Otolaryngol Head Neck Surg 1995; 121:769-772.
82. Yoshida H, Hirozane K, Kamiya A. Comparative study of autologous fibrin glues prepared by cryo-centrifugation, cryo-filtration, and ethanol precipitation methods. Biol Pharm Bull 1999; 22:1222-1225.
83. Park JJ, Cintron JR, Siedentop KH, Orsay CP, Pearl RK, Nelson RL, et al. Technical manual for manufacturing autologous fibrin tissue adhesive. Dis Colon Rectum 1999; 42:1334-1338.
84. Quigley RL, Perkins JA, Gottner RJ, Curran RD, Kuehn BE, Hoff WJ, et al. Intraoperative procurement of autologous fibrin glue. Ann Thorac Surg 1993; 56:387-389.
85. Redl H. Invited comment. Eur J Cardiothorac Surg 1992; 6, 54.
86. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 1994; 75:521-538.
87. Blomback B. Fibrinogen structure, activation, polymerization and fibrin gel structure. Thromb Res 1994; 75:327-328.
88. Hartman AR, Galanakis DK, Honig MP, Seifert FC, Anagnostopoulos CE. Autologous whole plasma fibrin gel. Intraoperative procurement. Arch Surg 1992; 127:357-359.
89. Kjaergard HK, Weis-Fogh US, Sørensen H, Thiis J, Hern J, Rygg I. Autologous fibrin glue - clinical use and sealing of high-porosity vascular prostheses. Vascular Surgery 1993; 27(4), 249-252.
90. Haverich A, Maatz W, Stegmann T, Oelert H, Borst HG. Experimental and clinical experiences with double-velour woven Dacron prostheses. Thorac Cardiovasc Surg 1986; 34:52-53.
91. Norgren L, Holtas S, Persson G, Ribbe E, Saxne T, Thorne J. Immune response to collagen impregnated Dacron double velour grafts for aortic and aorto-femoral reconstructions. Eur J Vasc Surg 1990; 4:379-384.
92. Mazzucotelli JP, Klein-Soyer C, Beretz A, Brisson C, Archipoff G, Cazenave JP. Endothelial cell seeding: coating Dacron and expanded polytetrafluoroethylene vascular grafts with a biological glue allows adhesion and growth of human saphenous vein endothelial cells. Int J Artif Organs 1991; 14:482-490.
93. Zilla P, Fasol R, Preiss P, Kadletz M, Deutsch M, Schima H, et al. Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts. Surgery 1989; 105:515-522.
94. Boyce ST, Holder IA, Supp AP, Warden GD, Greenhalgh DG. Delivery and activity of antimicrobial drugs released from human fibrin sealant. J Burn Care Rehabil 1994; 15:251-255.
95. Kram HB, Bansal M, Timberlake O, Shoemaker WC. Antibacterial effects of fibrin glue-antibiotic mixtures. J Surg Res 1991; 50:175-178.
96. Park MS, Kim YB. Sustained release of antibiotic from a fibrin-gelatin-antibiotic mixture. Laryngoscope 1997; 107:1378-1381.
97. Redl H, Schlag G, Stanek G, Hirschl A, Seelich T. In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 1983; 4:29-32.
98. Schwartz RJ, Dubrow TJ, Rival RA, Wilson SE, Williams RA. The effect of fibrin glue on intraperitoneal contamination in rats treated with systemic antibiotics. J Surg Res 1992; 52:123-126.
99. Thompson DF, Davis TW. The addition of antibiotics to fibrin glue. South Med J 1997; 90:681-684.
100. Haverich A, Hirt S, Karck M, Siclari F, Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 1992; 15:187-193.
101. Ney AL, Kelly PH, Tsukayama DT, Bubrick MP. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. J Trauma 1990; 30:1000-1005.
102. Bergsland J, Kalmbach T, Balu D, Feldman MJ, Caruana JA, Gage AA. Fibrin seal - an alternative to suture repair in experimental pulmonary surgery. J Surg Res 1986; 40:340-345.
103. Cziperle DJ, Joyce KA, Tattersall CW, Henderson SC, Cabusao EB, Garfield JD, et al. Albumin impregnated vascular grafts: albumin resorption and tissue reactions. J Cardiovasc Surg (Torino) 1992; 33:407-414.
104. Aksnes J, Foose E, Pilgram-Larsen J, Fjeld N. Injuries to the heart. Injury 1993; 24:545-548.
105. Jakob H, Campbell CD, Qiu ZK, Pick R, Replogle RL. Evaluation of fibrin sealing for cardiovascular surgery. Circulation 1984; 70:1138-1146.
106. Stark J, de Leval M. Experience with fibrin seal (Tisseel) in operations for congenital heart defects. Ann Thorac Surg 1984; 38:411-413.
107. Goldman BS, Del Rizzo DF. Treatment of acute cardiac rupture by autologous pericardial patch without infarctectomy. J Card Surg 1994; 9:374-375.
108. Leca F, Karam J, Vouhe PR, Khoury W, Tamisier D, Bical O, et al. Surgical treatment of multiple ventricular septal defects using a biologic glue. J Thorac Cardiovasc Surg 1994; 107:96-102.
109. McCarthy PM, Trastek VF, Bell DG, Buttermann GR, Piehler JM, Payne WS, et al. The effectiveness of fibrin glue sealant for reducing experimental pulmonary ari leak. Ann Thorac Surg 1988; 45:203-205.
110. Fleisher AG, Evans KG, Nelems B, Finley RJ. Effect of routine fibrin glue use on the duration of air leaks after lobectomy. Ann Thorac Surg 1990; 49:133-134.
111. Matar AF, Hill JG, Duncan W, Orfanakis N, Law I. Use of biological glue to control pulmonary air leaks. Thorax 1990; 45:670-674.
112. Mouritzen C, Dromer M, Keinecke HO. The effect of fibrin glueing to seal bronchial and alveolar leakages after pulmonary resections and decortications. Eur J Cardiothorac Surg 1993; 7:75-80.
113. Wong K, Goldstraw P. Effect of fibrin glue in the reduction of postthoracotomy alveolar air leak. Ann Thorac Surg 1997; 64:979-981.
114. Freiman JA, Chalmers TC, Smith HJ, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978; 299:690-694.
115. Spotnitz WD, Dalton MS, Baker JW, Nolan SP. Reduction of perioperative hemorrhage by anterior mediastinal spray application of fibrin glue during cardiac operations. Ann Thorac Surg 1987; 44:529-531.
116. Tanemoto K, Hata T, Tsushima Y, Konaga E. Use of fibrin glue at the anterior mediastinum to reduce postoperative drainage in cardiac surgery. J Jpn Assoc Thorac Surg 1998; 26, 942-946.
117. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989; 97:194-203.
118. Kjaergard HK. Control of bleeding from fragile stemum with a resorbable hemostyptic - reply to the editor. Ann Thorac Surg 2001; 71, 760.
119. Watanabe G, Misaki T, Kotoh K. Microfibrillar collagen (Avitene) and antibiotic-containing fibrin-glue after median stemotomy. J Card Surg 1997; 12:110-111.
120. Baker JW, Spotnitz WD, Nolan SP. A technique for spray application of fibrin glue during cardiac operations. Ann Thorac Surg 1987; 43:564-565.
121. Baker JW, Spotnitz WD, Matthew TL, Fechner RE, Nolan SP. Mediastinal fibrin glue: hemostatic effect and tissue response in calves. Ann Thorac Surg 1989; 47:450-452.
122. Blinder D, Manor Y, Martinowitz U, Taicher S, Hashomer T. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:137-140.
123. Bulajic P, Savic N, Djordjevic Z, Kecmanovic D, Bulajic M, Milicevic M, et al. Role of autologous fibrin tissue adhesive in abdominal surgery. Acta Chir Iugosl 1999; 46:43-45.
124. Chang H, Wu GJ, Perng WL, Hwang FY, Hung CR. Effects of fibrin glue on hemostasis. J Formos Med Assoc 1992; 91:601-607.
125. Dickneite G, Metzner H, Nicolay U. Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIII. J Surg Res 2000; 93:201-205.
126. Greenhalgh DG, Gamelli RL, Lee M, Delavari M, Lynch JB, Hansbrough JF, et al. Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds. J Trauma 1999; 46:433-440.
127. Ismail S, Combs MJ, Goodman NC, Teotia SS, Teates CD, Abbott RD, et al. Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant. Cathet Cardiovasc Diagn 1995; 34:88-95.
128. Isogai N, Fukunishi K, Kamiishi H. Use of fibrin glue to minimize bleeding of microvascular repairs in hypertensive rats. Microsurgery 1992; 13:321-324.
129. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 1996; 7:737-746.
130. Jakob H, Campbell CD, Qiu ZK, Pick R, Replogle RL. Use of fibrin sealant for reinforcing arterial anastomoses. J Vasc Surg 1984; 1:171-180.
131. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999; 81:1580-1588.
132. Prior JJ, Wallace DG, Harner A, Powers N. A sprayable hemostat containing fibrillar collagen, bovine thrombin, and autologous plasma. Ann Thorac Surg 1999; 68:479-485.
133. Spotnitz WD, Falstrom JK, Rodeheaver GT. The role of sutures and fibrin sealant in wound healing. Surg Clin North Am 1997; 77:651-669.
134. Tawes RL, Sydorak GR, DuVall TB. Autologous fibrin glue: the last step in operative hemostasis. Am J Surg 1994; 168:120-122.
135. Walterbusch G, Haverich A, Borst HG. Clinical experience with fibrin glue for local bleeding control and sealing of vascular prostheses. Thorac Cardiovasc Surg 1982; 30:234-235.
136. Zusman SP, Lustig JP, Bin NG. Cost evaluation of two methods of post tooth extraction hemostasis in patients on anticoagulant therapy. Community Dent Health 1993; 10:167-173.
137. Falworth MS, Butler PM, Powell BW. The use of fibrin glue to prevent seroma formation following sentinel, node biopsy. Plast Reconstr Surg 1999; 104:2331-2332.
138. Siedentop KH, O'Grady K, Park JJ, Bhattacharya T, Sanchez B. Fibrin sealant for treatment of cerebrospinal fluid leaks. Am J Otol 1999; 20:777-780.
139. Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg 1997; 63:97-102.
140. Tulandi T. Effects of fibrin sealant on tubal anastomosis and adhesion formation. Fertil Steril 1991; 56:136-138.
141. Davidson BR, Burnett S, Javed MS, Seifalian A, Moore D, Doctor N. Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy. Br J Surg 2000; 87:790-795.
142. Kitajiri S, Tabuchi K, Hiraumi H, Kaetsu H. Relief of post-tonsillectomy pain by release of lidocaine from fibrin glue. Laryngoscope 2001; 111:642-644.
143. Andreassen TT, Jorgensen PH. Biomechanical properties and collagen formation in subcutaneously implanted cellulose sponges treated with fibrin sealant. Eur Surg Res 1985; 17:264-268.
144. Brunner FX. Histological findings in sutured and fibrin-glued microvascular anastomosis. Arch Otorhinolaryngol 1984; 240:311-318.
145. Cederholm-Williams SA. Therapeutic use of fibrin - a new class of fibrin sealant with minimal risks. Ukr Biokhim Zh 1996; 68:34-36.
146. Chekanov V, Nikolaychik V, Tchekanov G. The use of biologic glue for better adhesions between the skeletal muscle flap and the myocardium and for increasing capillary ingrowth. J Thorac Cardiovasc Surg 1996; 111:678-680.
147. Dunn CJ, Goa KL. Fibrin sealant: a review of its use in surgery and endoscopy. Drugs 1999; 58:863-886.
148. Gauwerky JF, Klose RP, Forssmann WG. Fibrin glue for anastomosis of the fallopian tube-morphology. Hum Reprod 1993; 8:2108-2114.
149. Harmanli OH, Wapner RJ, Lontz JF. Efficacy of fibrin glue for in vitro sealing of human chorioamniotic membranes. J Reprod Med 1998; 43:986-990.
150. Jonas RA, Schoen FJ, Levy RJ, Castaneda AR. Biological sealants and knitted Dacron: porosity and histological comparisons of vascular graft materials with and without collagen and fibrin glue pretreatments. Ann Thorac Surg 1986; 41:657-663.
151. Kalmar P, Krebber HJ, Pokar H, Tilsner V. Bioadhesives in cardiac and vascular surgery. Thorac Cardiovasc Surg 1982; 30:230-231.
152. Stuart JD, Morgan RF, Kenney JG. Single-donor fibrin glue for hand bums. Ann Plast Surg 1990; 24:524-527.
153. Suwannuraks M, Chuansumrit A, Sriudompom N. The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients. Haemophilia 1999; 5:106-108.
154. von Segesser LK, Fasnacht MS, Vogt PR, Genoni M, Arbenz U, Turina MI. Prevention of residual ventricular septal defects with fibrin sealant. Ann Thorac Surg 1995; 60:511-515.
155. Wolner E. Fibrin gluing in cardiovascular surgery. Thorac Cardiovasc Surg 1982; 30:236-237.
156. Brennan M. Fibrin glue. Blood Rev 1991; 5:240-244.
157. Brown DM, Barton BR, Young VL, Pruitt BA. Decreased wound contraction with fibrin glue-treated skin grafts Arch Surg 1992; 127:404-406.
158. de Moraes AM, Annichino-Bizzacchi JM, Rossi AB. Use of autologous fibrin glue in dermatologic surgery: application of skin graft and second intention healing. Rev Paul Med 1998; 116:1747-1752.
159. Evrard VA, De Bellis A, Boeckx W, Brosens IA. Peritoneal healing after fibrin glue application: a comparative study in a rat model. Hum Reprod 1996; 11:1877-1880.
160. Kirkegaard P, Madsen PV. Perineal sinus after removal of the rectum. Occlusion with fibrin adhesive. Am J Surg 1983; 145:791-794.
161. Lee KH, Kim MS, Hahn TW, Kim JH. Comparison of histologic findings in wound healing of rabbit scleral homografts with fibrin glue (Tisseel) and suture material. J Refract Surg 1995; 11:397-401.
162. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985; 43:605-611.
163. Moller JF, Petersen JK. Efficacy of a fibrin sealant on healing of extraction wounds. Int J Oral Maxillofac Surg 1988; 17:142-144.
164. Kjaergard HK, Weis-Fogh US, Sorensen H, Thiis JJ, Rygg I. [Autologous fibrin glue-preparation and clinical use]. Ugeskr Laeger 1992; 154:1554-1556.
165. Kacker A, Huo J. Reinforcement of an end-to-end tracheal resection anastomosis with fibrin glue: a case report. Ear Nose Throat J 2001; 80:234-6, 238.
166. Moore M, Burak WEJ, Nelson E, Kearney T, Simmons R, Mayers L, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 2001; 192:591-599.
167. Sentovich SM. Fibrin Glue for All Anal Fistulas. J Gastrointest Surg 2001; 5:158-161.
168. Honig JF, Merten HA. Surgical removal of intra- and extraoral cavernous lymphangiomas using intraoperative-assisted intralesional fibrin glue injections. J Craniofac Surg 2000; 11:42-45.
169. Nervi C, Gamelli RL, Greenhalgh DG, Luterman A, Hansbrough JF, Achauer BM, et al. A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in bum patients. J Burn Care Rehabil 2001; 22:99-103.
170. Dinsmore RC, Harris JA, Gustafson RJ. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. Am Surg 2000; 66:982-985.
171. Duchesne B, Tahi H, Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea 2001; 20:230-232.
172. Siedentop KH, Park JJ, Shah AN, Bhattacharyya TK, O'grady KM. Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001; 22:230-235.
173. Horowitz B, Prince AM, Horowitz MS, Watklevicz C. Viral safety of solvent-detergent treated blood products. Dev Biol Stand 1993; 81:147-161.
174. Dresdale A, Bowman FO, Malm JR, Reemtsma K, Smith CR, Spotnitz HM, et al. Hemostatic effectiveness of fibrin glue derived from single-donor fresh frozen plasma. Ann Thorac Surg 1985; 40:385-387.
175. Reiss RF, Oz MC. Autologous fibrin glue: production and clinical use. Transfus Med Rev 1996; 10:85-92.
176. Weisman RA, Torsiglieri AJ, Schreiber AD, Epstein GH. Biochemical characterization of autologous fibrinogen adhesive. Laryngoscope 1987; 97:1186-1190.
177. Mosesson MW. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coagul Fibrinolysis 1997; 8:257-267.
178. Pisano JJ, Finlayson JS, Peyton MP. [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine.]. Science 1968; 160: 892-893.
179. Aronson DL. Comparison of the actions of thrombin and the thrombin-like venom enzymes ancrod and batroxobin. Thromb Haemost 1976; 36:9-13.
180. Bell WRJ. Defibrinogenating enzymes. Drugs 1997; 54 Suppl 3:18-30.
181. Latallo ZS. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes - a multicentre trial. Thromb Haemost 1983; 50:604-609.
182. Vankemmel O, de La Taille A, Burnouf T, Rigot JM, Duchene F, Mazeman E. Evaluation of a fibrin sealant free of bovine-derived components in an experimental vas anastomosis study. Urol Int 2000; 65:196-199.
183. Yoshida H, Kamiya A. Prevention of the adverse effects of aprotinin in autologous fibrin glue. Biol Pharm Bull 2001; 24:106-109.
184. Scott NJ. Risk assessment of viral load and aerosols in Vivostat system derived fibrin sealant. Internal report 2000; 1-3.
185. Kjaergard HK, Thiis J, Wiinberg N. Accidental injuries and blood exposure to cardiothoracic surgical teams. Eur J Cardiothorac Surg 1992; 6:215-217.
186. Brearley S, Buist LJ. Blood splashes: an underestimated hazard to surgeons. BMJ 1989; 299:1315
187. Anonymous. Fatal Cercopithecine herpesvirus 1 (B virus) infection following a mucocutaneous exposure and interim recommendations for worker protection. MMWR Morb Mortal Wkly Rep 1998; 47:1073-1076.
188. Berry K. Reducing the risk of eye contamination. Nurs Stand 1995; 9:27-29.
189. McCarthy PM. Fibrin glue in cardiothoracic surgery. Transfus Med Rev 1993; 7:173-179.
190. Lindenberg S, Lauritsen JG. Prevention of peritoneal adhesion formation by fibrin sealant. An experimental study in rats. Ann Chir Gynaecol 1984; 73:11-13.
191. Lindenberg S, Steentoft P, Sorensen SS, Olesen HP. Studies on prevention of intra-abdominal adhesion formation by fibrin sealant. An experimental study in rats. Acta Chir Scand 1985; 151:525-527.
192. Dickson CS, Magovern JA. The effect of fibrin glue on the formation of perivascular adhesions. Vascular Surgery 1993; 27:15-18.
193. Joyce DH, Cichon R, Muralidharan S, Gu J, McGrath LB. Alteration in pericardial adhesion formation following pretreatment with fibrin glue. J Appl Biomater 1991; 2:269-271.
194. Moro H, Hayashi J, Ohzeki H, Nakayama T, Namura O, Hanzawa K et al. The effect of fibrin glue on inhibition of pericardial adhesions. Jpn J Thorac Cardiovasc Surg 1999; 47:79-84.
195. Harris ES, Morgan RF, Rodeheaver GT. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 1995; 117:663-669.
196. De Iaco P, Costa A, Mazzoleni G, Pasquinelli G, Bassein L, Marabini A. Fibrin sealant in laparoscopic adhesion prevention in the rabbit uterine horn model. Fertil Steril 1994; 62:400-404.
197. Chmielewski GW, Saxe JM, Dulchavsky SA, Diebel LN, Bailey JK. Fibrin gel limits intra-abdominal adhesion formation. Am Surg 1992; 58:590-592.
198. de Virgilio C, Dubrow T, Sheppard BB, MacDonald WD, Nelson RJ, Lesavoy MA, et al. Fibrin glue inhibits intra-abdominal adhesion formation. Arch Surg 1990; 125:1378-1381.
199. Koltai JL, Gerhard A. Intraperitoneal application of fibrinogen gluing in the rat for adhesions prophylaxis. Prog Pediatr Surg 1990; 25:71-80.
200. Kjaergard HK. Suture support: Is it advantageous? Am J Surg 2001; 182:15S-20S.
201. Itokazu M, Yamamoto K, Yang WY, Aoki T, Kato N, Watanabe K. The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis. Infection 1997; 25:359-363.
202. Moesgaard F, Hoffmann S, Nielsen R. Successful fibrin seal closure of a contaminated fistula. Case report. Acta Chir Scand 1989; 155:427-428.
203. Schlosser RJ, Spotnitz WD, Rodeheaver G, Scheld WM, Iezzoni J, Gross CW. Effects of fibrin sealant-containing antibiotics in a rabbit model of chronic sinusitis. Am J Rhinol 2000; 14:233-240.
204. Tanemoto K, Fujinami H. Experimental study on bacterial colonization of fibrin glue and its prevention. Clin Ther 1994; 16:1016-1027.
205. Watanabe G, Haverich A, Speier R, Dresler C, Borst HG. Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg 1994; 107:171-177.
206. Yin Q, Kemp GJ, Yu LG, Wagstaff SC, Frostick SP. Neurotrophin-4 delivered by fibrin glue promotes peripheral nerve regeneration. Muscle Nerve 2001; 24:345-351.
207. McGinnis DE, Strup SE, Gomella LG. Management of hemorrhage during laparoscopy. J Endourol 2000; 14:915-920.